drugset / Trial / NCT01822041
14C-ARN-509 Microtracer Label AME and Absolute BA Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is study in healthy human volunteers to determine the absorption, metabolism, and excretion (AME) profile of ARN-509 as well as its absolute oral bioavailability (BA).
Timeline
- Start
- 2013-03
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apalutamide | Small molecule | 100 ug | Oral |
| Comparator | Apalutamide | Small molecule | 240 mg | Oral |
Indications
No indication recorded.